Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: PFE

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
Uncategorized

Moderna Inks Supply Pact Of 500M COVID-19 Vaccine Doses To COVAX Effort Starting Q4

By Vandana Singh
Today, 4:28 AM
Moderna Inc (NASDAQ: MRNA) has announced an agreement with vaccine promoter Gavi to supply up to 500 million doses of its COVID-19…

AZN

Read More
1 minute read
Uncategorized

Pfizer tol Begin Distributing Smaller Packages of Covid-19 Vaccine to U.S. States by the End of May to Reduce Potential Waste

By Charles Gross
Today, 4:28 AM
-Axios https://www.axios.com/pfizer-covid-vaccine-packaging-demand-decreases-2d3775b6-dd22-4c31-9007-fcd06e31b703.html

BNTX

Read More
3 minute read
Uncategorized

Who Is — And Will Be — Making Money From COVID-19 Vaccines?

By Financialounge.com
Today, 4:28 AM
Schroders' Expert John Bowler Analyzes The Pharmaceutical Groups Involved In COVID-19 Drug Development, Emphasizing That Their Efforts Will Be Rewarded In The Future, Despite Current Low Benefits.

AZN

Read More
8 minute read
Uncategorized

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge

By Shanthi Rexaline
Today, 4:28 AM
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.

ABUS

Read More
5 minute read
Uncategorized

Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates

By Shanthi Rexaline
Today, 4:28 AM
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May.

ACAD

Read More
1 minute read
Uncategorized

Two Doses Pfizer-BioNTech COVID-19 Vaccine Necessary To Generate Immune Response Against Variants, UK Study Show: Reuters

By Vandana Singh
Today, 4:28 AM
According to a U.K. study, a single dose of Pfizer Inc (NYSE: PFE) – BioNTech SE's (NASDAQ: BNTX) coronavirus vaccine may not generate a…

BNTX

Read More
1 minute read
Uncategorized

Pfizer Shares Quiet Amid Report Canada Will Begin Receiving Pfizer COVID-19 Vaccines From US Next Week

By Benzinga Newsdesk
Today, 4:28 AM
-AP

EWC

Read More
1 minute read
Uncategorized

Novavax Secures Additional $147M From Warp Speed Program For COVID-19 Vaccine

By Vandana Singh
Today, 4:28 AM
According to an SEC filing, Novavax Inc (NASDAQ: NVAX) has received an additional $147.3M as part of Operation Warp Speed to…

AZN

Read More
2 minute read
Uncategorized

Pfizer Said To Have Begun Exporting US-Made COVID-19 Vaccine

By Madhukumar Warrier
Today, 4:28 AM
Pfizer Inc. (NYSE: PFE) has started exporting COVID-19 vaccine doses produced in its U.S.

AZN

Read More
1 minute read
Uncategorized

Pfizer-BioNTech Bullish On COVID-19 Vaccine Trial Results In Infants By September: Reuters

By Vandana Singh
Today, 4:28 AM
BioNTech SE's (NASDAQ: BNTX) CEO Ugur Sahin says the company, along with its partner Pfizer Inc (NYSE: PFE), could have data from trials…

AZN

Posts navigation

Previous 1 … 158 159 160 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service